Two new drugs for obesity are getting close to approval

    Two new drugs for obesity are getting close to approval...sibutramine (Meridia, Knoll) and orlistat (Xenical, Roche).

    Sibutramine is a serotonin AND norepinephrine reuptake inhibitor. It's similar to the antidepressant Effexor (venlafaxine).

    Sibutramine reduces appetite and increases metabolism...but it can also raise blood pressure.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote